Contribution of rivaroxaban to the international normalized ratio when switching to warfarin for anticoagulation as determined by simulation studies

Siegmund Hans-Ulrich; Burghaus Rolf; Kubitza Dagmar; Coboeken Katrin

首页> 外文期刊>British Journal of Clinical Pharmacology >Contribution of rivaroxaban to the international normalized ratio when switching to warfarin for anticoagulation as determined by simulation studies

【24h】

Contribution of rivaroxaban to the international normalized ratio when switching to warfarin for anticoagulation as determined by simulation studies

机译：通过模拟研究确定，利伐沙班在改用华法林进行抗凝治疗时对国际标准化比率的贡献

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

AimThis study evaluated the influence of rivaroxaban 20mg once daily on international normalized ratio (INR) during the co-administration period when switching from rivaroxaban to warfarin.

机译：目的这项研究评估了在从利伐沙班转为华法林的共同给药期间，每日一次利伐沙班20mg对国际标准化比率（INR）的影响。

著录项

来源
《British Journal of Clinical Pharmacology》 |2015年第6期|共8页
作者
Siegmund Hans-Ulrich; Burghaus Rolf; Kubitza Dagmar; Coboeken Katrin;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
international normalized ratio; prothrombin time; rivaroxaban; simulation; switch of medication; warfarin;

机译：国际标准化比率;凝血酶原时间;利伐沙班;模拟;用药转换;华法林;
入库时间 2022-08-18 09:14:21

相似文献

外文文献
中文文献
专利

1. Contribution of rivaroxaban to the international normalized ratio when switching to warfarin for anticoagulation as determined by simulation studies [J] . Siegmund Hans-Ulrich, Burghaus Rolf, Kubitza Dagmar, British Journal of Clinical Pharmacology . 2015,第6期

机译：通过模拟研究确定，利伐沙班在改用华法林进行抗凝治疗时对国际标准化比率的贡献
2. WARFARIN ANTICOAGULATION VARIABILITY, TESTING, AND DOSE-ADJUSTMENT FREQUENCY IS REDUCED IN CLINICAL PRACTICE AFTER SWITCH FROM PROTHROMBIN TIME BASED INTERNATIONAL NORMALIZED RATIO (INR) TO FIIX-PROTHROMBIN TIME BASED NORMALIZED RATIO (FIIX-NR). [J] . Gudmundsdottir Brynja R., Onundarson Pall T. American Journal of Hematology . 2018,第9期

机译：从凝血酶原时间的国际归一化比（INR）从基于凝血酶体时间（INR）到Fiix - 凝血酶原基的归一化比（FIIX-NR）切换后，在临床实践中减少了临床实践中的临床实践中的临床实践中的临床实践。
3. The International Normalized Ratio during Concurrent Warfarin and Argatroban Anticoagulation: Differential Contributions of Each Agent and Effects of the Choice of Thromboplastin Used [J] . Gary D. Knappenberger, James L. Joffrion, James L. Zehnder, Clinical Chemistry: Journal of the American Association for Clinical Chemists . 1999,第3期

机译：华法林和阿加曲班同时抗凝期间的国际标准化比率：每种药物的差异贡献和使用的促凝血酶原蛋白选择的影响
4. NATIONALLY DETERMINED CONTRIBUTIONS: HOW REFRIGERATION SHOULD BE INCLUDED REFRIGERATION [C] . Didier Coulomb SECOP;IIR Conference on Compressors and Refrigerants;embraco;DAIKIN . -1

机译：国家决定的贡献：如何包括制冷剂的制冷
5. Cost-Effectiveness of Current Anticoagulation Care versus Genetic Testing of CYP2C9 and VKORC1 Prior to Long-Term Warfarin Anticoagulation Care: The Implementation of Discrete Event Simulation Model on the Natural History of Venous Thromboembolism. [D] . Teschemaker, Anna R. 2011

机译：当前抗凝治疗的成本效果与长期华法林抗凝治疗之前的CYP2C9和VKORC1遗传检测的关系：基于静脉血栓栓塞自然史的离散事件模拟模型的实现。
6. Contribution of rivaroxaban to the international normalized ratio when switching to warfarin for anticoagulation as determined by simulation studies [O] . Hans-Ulrich Siegmund, Rolf Burghaus, Dagmar Kubitza, 2015

机译：通过模拟研究确定利伐沙班在改用华法林进行抗凝治疗时对国际标准化比率的贡献
7. Contribution of rivaroxaban to the international normalized ratio when switching to warfarin for anticoagulation as determined by simulation studies [O] . Hans-Ulrich Siegmund, Rolf Burghaus, Dagmar Kubitza, 2015

机译：通过模拟研究确定的抗凝血对抗凝血时，罗弗索拉巴兰对国际标准化比率的贡献

Contribution of rivaroxaban to the international normalized ratio when switching to warfarin for anticoagulation as determined by simulation studies

摘要

著录项

相似文献

相关主题

期刊订阅